Patent Foramen Ovale clinical trials at UCSF
2 in progress, 1 open to eligible people
Showing trials for
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
open to eligible people ages 18-70
This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
San Francisco, California and other locations
AMPLATZER PFO Occluder Post Approval Study
Sorry, not currently recruiting here
The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.
San Francisco, California and other locations
Last updated: